pancratistatin has been researched along with Cancer of Colon in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Liu, DY; Shen, RR; Xiong, Y; Xiong, YJ | 1 |
Griffin, C; Karnik, A; McNulty, J; Pandey, S | 1 |
Bibby, MC; Cooper, PA; Gill, JH; Millington, NJ; Shnyder, SD | 1 |
3 other study(ies) available for pancratistatin and Cancer of Colon
Article | Year |
---|---|
Pancratistatin Inhibits the Growth of Colorectal Cancer Cells by Inducing Apoptosis, Autophagy, and G2/M Cell Cycle Arrest.
Topics: Amaryllidaceae Alkaloids; Apoptosis; Autophagy; Cell Cycle; Cell Cycle Checkpoints; Cell Division; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Colonic Neoplasms; Colorectal Neoplasms; G2 Phase Cell Cycle Checkpoints; Humans; Isoquinolines | 2019 |
Pancratistatin selectively targets cancer cell mitochondria and reduces growth of human colon tumor xenografts.
Topics: Amaryllidaceae Alkaloids; Animals; Apoptosis; bcl-2-Associated X Protein; Caspases; Cell Death; Cell Line, Tumor; Colon; Colonic Neoplasms; DNA Damage; Enzyme Activation; Fibroblasts; HCT116 Cells; HT29 Cells; Humans; Isoquinolines; Male; Mice; Mice, Nude; Microtubules; Mitochondria; Transplantation, Heterologous; Tubulin; Xenograft Model Antitumor Assays | 2011 |
Sodium pancratistatin 3,4-o-cyclic phosphate, a water-soluble synthetic derivative of pancratistatin, is highly effective in a human colon tumor model.
Topics: Amaryllidaceae Alkaloids; Antineoplastic Agents, Phytogenic; Benzimidazoles; Cell Cycle; Colonic Neoplasms; Dose-Response Relationship, Drug; Fluorescent Dyes; Humans; Inhibitory Concentration 50; Isoquinolines; Microtubules; Models, Biological; Molecular Structure; Solubility; Tumor Cells, Cultured; Water | 2008 |